Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

.2012 Aug;12(4):368-72.
doi: 10.7861/clinmedicine.12-4-368.

PET/CT in oncology

Affiliations

PET/CT in oncology

Fahim-Ul-Hassan et al. Clin Med (Lond).2012 Aug.
No abstract available

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Hodgkin's disease: (a) Coronal images show increased metabolic activity in multiple lymph nodes above and below the diaphragm and a large anterior mediastinal mass. (b) Post-chemotherapy, there is complete resolution of18F-FDG uptake in lymph nodes and mediastinal mass, in keeping with a complete metabolic response.
Fig 2.
Fig 2.
High-grade glioma: (a) Transaxial brain scan shows increased11C-methionine in a left frontal lobe lesion; (b)18F-FDG PET/CT shows increased metabolic activity at the same site indicating a high-grade tumour.
Fig 3.
Fig 3.
Oesophageal cancer. Coronal18F-FDG images show intense abnormal activity in a left paratracheal lymph node (top arrow), distal thickened oesophagus (middle arrow) and a left adrenal metastasis (bottom arrow).
Fig 4.
Fig 4.
Melanoma: (a) Coronal views of18F-FDG PET/CT show multiple metastases in lynph nodes, lungs, skeleton and liver. (b) Coronal and axial fused PET/CT images also localise abnormal uptake in various muscles (arrows).
See this image and copyright information in PMC

References

    1. Weber G. Enzymology of cancer cells (second of two parts). Review. N Engl J Med 1977;296:541–551. 10.1056/NEJM197703102961005 - DOI - PubMed
    1. Weber G. Enzymology of cancer cells (first of two parts). Review. N Engl J Med 1977;296:486–492. 10.1056/NEJM197703032960905 - DOI - PubMed
    1. The Royal College of Radiologists. Evidence-based indications for the use of PET-CT in the United Kingdom 2012. London: RCR, 2012.http://www.rcr.ac.uk/publications.aspx?PageID = 310&PublicationID = 363, [Accessed 2 July 2012] - PubMed
    1. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010;37:181–200. 10.1007/s00259-009-1297-4 - DOI - PMC - PubMed
    1. Gould MK, Maclean CC, Kushner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914–924. 10.1001/jama.285.7.914 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2026 Movatter.jp